Be part of the knowledge.™

CME/CE

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.

2608

LikeLikedUnlike

Episodes 331-345 of 745

Advancing Care in Non-Clear Cell RCC: Optimizing ICI and TKIs
CME/CE
Advancing Care in Non-Clear Cell RCC: Optimizing ICI and TKIs
- Pedro Barata, MD, MSc, FACP
  Peer
- Sumanta K. Pal, MD, FASCO
  Peer
1.00 credits
New Frontiers in the Treatment of DMD Across the Age Spectrum
CME/CE
New Frontiers in the Treatment of DMD Across the Age Spectrum
- Crystal Proud, MD
  Peer
- John Brandsema, MD
  Peer
- Omer Abdul Hamid, MD
  Peer
1.00 credits
Insights from Experts: Preventing and Managing CMV Post-Solid Organ Transplant
CME/CE
Insights from Experts: Preventing and Managing CMV Post-Solid Organ Transplant
- Fernanda P. Silveira, MD, MS, FIDSA, FAST
  Peer
- Jennifer Saullo, MD, PharmD, FIDSA
  Peer
0.75 credits
New Strategies for Individualizing Treatment in DME
CME/CE
New Strategies for Individualizing Treatment in DME
- Luis A. Gonzalez, MD, MPH
  Peer
- Jeremiah Brown Jr., MD, MS, FASRS
  Peer
0.25 credits
From Doctor-Speak to Patient-Speak: Bridging the Communication Gap
CME/CE
From Doctor-Speak to Patient-Speak: Bridging the Communication Gap
- Luis A. Gonzalez, MD, MPH
  Peer
- Jeremiah Brown Jr., MD, MS, FASRS
  Peer
0.25 credits
Time Is Bone: Making the Case for Early Anabolic Treatment in Osteoporosis
CME/CE
Time Is Bone: Making the Case for Early Anabolic Treatment in Osteoporosis
- Kendall Moseley, MD
  Peer
- Kenneth G. Saag, MD
  Peer
0.25 credits
advertisement
Treatment Advances in Generalized Myasthenia Gravis: A Pathophysiology-Driven Framework Leveraging FcRn Therapeutics
CME/CE
Treatment Advances in Generalized Myasthenia Gravis: A Pathophysiology-Driven Framework Leveraging FcRn Therapeutics
- Vera Bril, MD
  Peer
- Neelam Goyal, MD
  Peer
0.75 credits
MinuteCE®
Advances in Hemophilia Treatment: Perspectives From Your Colleagues
- Stephanie Ambrose, DO
  Peer
- Jenny McDaniel, MD
  Peer
1.25 credits 10 episodes
An Overview of Current and Emerging Treatment Options for Hemophilia A & B
MinuteCE®
An Overview of Current and Emerging Treatment Options for Hemophilia A & B
- Stephanie Ambrose, DO
  Peer
- Jenny McDaniel, MD
  Peer
1.25 program credits
The Impact of Hemophilia Across Patients’ Lives
MinuteCE®
The Impact of Hemophilia Across Patients’ Lives
- Stephanie Ambrose, DO
  Peer
- Jenny McDaniel, MD
  Peer
1.25 program credits
Evaluating Novel Factor Replacement Strategies: Extended and Ultra-Half-Life Factors and Factor Mimetics
MinuteCE®
Evaluating Novel Factor Replacement Strategies: Extended and Ultra-Half-Life Factors and Factor Mimetics
- Jenny McDaniel, MD
  Peer
- Stephanie Ambrose, DO
  Peer
1.25 program credits
Evaluating Emerging Treatment Options: Rebalancing Therapies
MinuteCE®
Evaluating Emerging Treatment Options: Rebalancing Therapies
- Stephanie Ambrose, DO
  Peer
- Jenny McDaniel, MD
  Peer
1.25 program credits
advertisement
The Promise and Future of Gene Therapy
MinuteCE®
The Promise and Future of Gene Therapy
- Stephanie Ambrose, DO
  Peer
- Jenny McDaniel, MD
  Peer
1.25 program credits
Considering the Promise of New and Emerging Treatments for Hemophilia: The Need for ITI?
MinuteCE®
Considering the Promise of New and Emerging Treatments for Hemophilia: The Need for ITI?
- Stephanie Ambrose, DO
  Peer
- Jenny McDaniel, MD
  Peer
1.25 program credits
Considering the Promise of New and Emerging Treatments for Hemophilia: Managing Thrombotic Risks
MinuteCE®
Considering the Promise of New and Emerging Treatments for Hemophilia: Managing Thrombotic Risks
- Jenny McDaniel, MD
  Peer
- Stephanie Ambrose, DO
  Peer
1.25 program credits

Program Chapters

Segment Chapters

Playlist:

Recommended